TDP-43 in Alzheimer's disease is not associated with clinical FTLD or Parkinsonism

scientific article

TDP-43 in Alzheimer's disease is not associated with clinical FTLD or Parkinsonism is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1026368866
P356DOI10.1007/S00415-014-7352-5
P932PMC publication ID4101047
P698PubMed publication ID24760339
P5875ResearchGate publication ID261839408

P50authorKeith A JosephsQ90859127
Jennifer L WhitwellQ99637904
Youngsin JungQ114336686
Dennis W. DicksonQ30504740
Clifford JackQ30505709
Melissa E. MurrayQ42734330
Ronald C. PetersenQ56839853
David S KnopmanQ63967707
Joseph E ParisiQ67209577
Bradley F BoeveQ67501037
P2860cites workSensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementiaQ24598142
Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosisQ28131672
Primate models of movement disorders of basal ganglia originQ29618489
TDP-43 is a key player in the clinical features associated with Alzheimer's diseaseQ34232167
Evaluation of subcortical pathology and clinical correlations in FTLD-U subtypesQ34604146
Temporal lobar predominance of TDP-43 neuronal cytoplasmic inclusions in Alzheimer diseaseQ36115656
TDP-43 immunoreactivity in hippocampal sclerosis and Alzheimer's diseaseQ37179756
Abnormal TDP-43 immunoreactivity in AD modifies clinicopathologic and radiologic phenotype.Q37425165
Staging TDP-43 pathology in Alzheimer's diseaseQ37621617
Concurrence of TDP-43, tau and alpha-synuclein pathology in brains of Alzheimer's disease and dementia with Lewy bodiesQ46396965
A retrospective study of the behavioural and psychological symptoms of mid and late phase Alzheimer's diseaseQ48611085
TDP-43 pathological changes in early onset familial and sporadic Alzheimer's disease, late onset Alzheimer's disease and Down's syndrome: association with age, hippocampal sclerosis and clinical phenotypeQ48864196
Phosphorylated TDP-43 in Alzheimer's disease and dementia with Lewy bodies.Q53299106
Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. The National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's DiseaseQ73789480
Parahippocampal tau pathology in healthy aging, mild cognitive impairment, and early Alzheimer's diseaseQ77614817
P433issue7
P921main subjectAlzheimer's diseaseQ11081
Parkinson's diseaseQ11085
parkinsonian syndromeQ1531991
P304page(s)1344-1348
P577publication date2014-04-24
P1433published inJournal of NeurologyQ6295649
P1476titleTDP-43 in Alzheimer's disease is not associated with clinical FTLD or Parkinsonism
P478volume261

Reverse relations

cites work (P2860)
Q92286200Associations between Comorbid TDP-43, Lewy Body Pathology, and Neuropsychiatric Symptoms in Alzheimer's Disease
Q50350613Biology and Pathobiology of TDP-43 and Emergent Therapeutic Strategies.
Q64385732Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report.
Q48287129Neuropathologically mixed Alzheimer's and Lewy body disease: burden of pathological protein aggregates differs between clinical phenotypes.
Q47727180Possible concurrence of TDP-43, tau and other proteins in amyotrophic lateral sclerosis/frontotemporal lobar degeneration.
Q38403182Progressive Supranuclear Palsy Syndrome and Semantic Dementia in Neuropathologically Proven Lewy Body Disease: A Report of Two Cases
Q90318261Synaptic Proteome Compensation and Resilience to Psychosis in Alzheimer's Disease
Q36217832TAR DNA-binding protein 43 and pathological subtype of Alzheimer's disease impact clinical features
Q53366738TDP-43 proteinopathies: pathological identification of brain regions differentiating clinical phenotypes.
Q90379423TDP-43: From Alzheimer's Disease to Limbic-Predominant Age-Related TDP-43 Encephalopathy
Q38529627The Role of TDP-43 in Alzheimer's Disease
Q48949710Updated TDP-43 in Alzheimer's disease staging scheme

Search more.